Patent ID: 11905274
Assignee: BEIJING TIDE PHARMACEUTICAL CO., LTD.
Field: Organic fine chemistry (Chemistry)
Classification: CPC C  A | IPC C

Claim 17:
18. The compound according to claim 5, or a pharmaceutically acceptable salt, ester, stereoisomer, polymorph, solvate, N-oxide, isotopically labeled compound, or prodrug thereof, wherein:
said C1-6 alkyl is selected from the group consisting of methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, isopentyl, neopentyl, 1-hexyl, 1-heptyl, and 1-octyl; and/or
said C2-6 alkenyl is selected from the group consisting of vinyl, 1-propenyl, 2-propenyl, 2-butenyl, 3-butenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl, and 2-hexenyl; and/or
said C2-6 alkynyl is selected from the group consisting of ethynyl, 1-propynyl, 2-propynyl, 2-butynyl, 3-butynyl, 2-pentynyl, 3-pentynyl, 4-pentynyl, 2-hexynyl, and 3-hexynyl; and/or
said C3-7 cyclic hydrocarbyl group is selected from the group consisting of cyclopropyl, cyclopentyl, and cyclohexyl; and/or
said 8- to 10-membered benzo-fused heterocyclic group is selected from the group consisting of, and/or
said 5- to 6-membered heteroaryl is selected from the group consisting of thienyl, furyl, pyrrolyl, oxazolyl, thiazolyl, imidazolyl, pyrazolyl, isoxazolyl, isothiazolyl, oxadiazolyl, triazolyl, tetrazolyl, thiadiazolyl, pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl and triazinyl; and/or
said —C1-6 alkylene-C6-10 aryl is —C1-4 alkylene-C6-10 aryl; and/or
said —C1-6 alkylene-(5- to 14-membered heteroaryl) is —C1-4 alkylene-(5- to 10-membered heteroaryl), wherein the heteroaryl is optionally selected from the group consisting of thienyl, furyl, pyrrolyl, oxazolyl, thiazolyl, imidazolyl, pyrazolyl, isoxazolyl, isothiazolyl, oxadiazolyl, triazolyl, tetrazolyl, thiadiazolyl, pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl and triazinyl and their benzo derivatives.